September 2026
The global cancer therapeutics market size was evaluated at USD 232.14 billion in 2026 and is expected to surpass around USD 501.07 billion by 2035 with a CAGR of 8.95%.
September 2026
The cancer therapeutics and biotherapeutics market size reached USD 228.73 billion in 2026, with leading cancer therapeutics and biotherapeutics market companies including Amgen Inc., Bristol-Myers Squibb, Celgene Corporation.
September 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.51 billion in 2026 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The global small cell lung cancer therapeutics market size is projected to hit around USD 22.86 billion by 2035 from USD 8.14 billion in 2026 with a CAGR of 12.17%.
September 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 2.14 billion in 2026 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
September 2026
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
September 2026
The global breast cancer therapeutics market size was valued at USD 35.91 billion in 2026 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
July 2026
The global next-generation cancer therapeutics market size was evaluated at USD 99.34 billion in 2026 and is predicted to hit around USD 186.65 billion by 2035, growing at a CAGR of 7.27%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 6.01 billion in 2026 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
July 2025
The pet cancer therapeutics market size was estimated at USD 448.03 million in 2023 and is projected to surpass around USD 1,150.70 million by 2034 with a CAGR of 9.89%.
September 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
September 2026
The next-generation RNA therapeutics market is growing with innovations in RNA-based drugs, improving treatments for cancer, genetic diseases, and infectious conditions.
September 2026
The global skin cancer diagnostic market size is evaluated at USD 9.42 billion in 2026 and is predicted to hit around USD 14.60 billion by 2035, with a CAGR of 4.99%.
September 2026
The gastric cancer diagnostics market size reached USD 1.42 billion in 2026, with leading gastric cancer diagnostics market companies including GE Healthcare, Siemens Healthineers.
September 2026
The breast cancer core needle biopsy market size stood at USD 1.08 billion in 2026, with major breast cancer core needle biopsy market companies including Intact Medical Corporation, Ethicon Surgical Technologies.
September 2026
The global bispecific antibody therapeutics contract manufacturing market size was evaluated at USD 13.4 billion in 2026 and is predicted to hit around USD 218.92 billion by 2035, growing at a CAGR of 36.4%.
September 2026
The global maternal health therapeutics market size was evaluated at USD 5.07 billion in 2026 and is predicted to hit around USD 9.64 billion by 2035, growing at a CAGR of 7.40%.
September 2026
The global genomics in cancer care market size was evaluated at USD 28.32 billion in 2026 and is predicted to hit around USD 108.69 billion by 2035, growing at a CAGR of 28.32%.
September 2026
The global lung cancer diagnostics market size is estimated at USD 5.69 billion in 2026 and is predicted to hit around USD 9.45 billion by 2034 with a CAGR of 6.53%.
September 2026
The Europe urinary incontinence therapeutics market was valued at USD 12.14 billion in 2026 and is expected to expand at a CAGR of 3.15% from 2026 to 2035. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The anti-inflammatory therapeutics market size was estimated at USD 113.58 billion in 2026 and is expected to hit USD 164.44 billion by 2035, with a CAGR of 4.14%.
September 2026
The global dermatology diagnostic devices and therapeutics market size is projected to hit around USD 31.33 billion by 2035 from USD 17.03 billion in 2026, with a CAGR of 7.02%.
September 2026
The U.S. digital therapeutics market size is exhibited at USD 4.56 billion in 2026 and is predicted to surpass USD 24.09 billion by 2035 with a remarkable CAGR of 20.54%.
September 2026
The global amyloidosis therapeutics market size was valued at USD 3.44 billion in 2026 and is expected to hit around 6.92 billion by 2035, growing at a CAGR of 8.09% from 2026 to 2035.
September 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.49 billion in 2026 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
September 2026
The mRNA vaccines and therapeutics market size reached USD 130.20Â billion in 2026 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
September 2026
The liver cancer drug market was valued at USD 5.19 billion in 2026, with leading companies including Bayer AG, Bristol Myers Squibb.
September 2026
The global prostate cancer market size is calculated at USD 13.97 billion in 2026 and is projected to hit around USD 28.83 billion by 2035 with a CAGR of 8.41%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com